Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non-muscle invasive bladder cancer: Findings from The Be-Well Study.

[1]  J. Witjes,et al.  Current best practice for bladder cancer: a narrative review of diagnostics and treatments , 2022, The Lancet.

[2]  J. Witjes,et al.  Limited Changes in Lifestyle Behaviours after Non-Muscle Invasive Bladder Cancer Diagnosis , 2022, Cancers.

[3]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[4]  S. McCann,et al.  Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non–Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process , 2021, JMIR cancer.

[5]  Nan-nan Dong,et al.  Sulforaphane induces S-phase arrest and apoptosis via p53-dependent manner in gastric cancer cells , 2021, Scientific Reports.

[6]  A. Lenis,et al.  Bladder Cancer: A Review. , 2020, JAMA.

[7]  C. Ambrosone,et al.  Effects of cooking methods on total isothiocyanate yield from cruciferous vegetables , 2020, Food science & nutrition.

[8]  Jack A. Taylor,et al.  A data mining approach to investigate food groups related to incidence of bladder cancer in the BLadder cancer Epidemiology and Nutritional Determinants International Study , 2020, British Journal of Nutrition.

[9]  G. Gakis.  Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and Perspectives. , 2020, European urology focus.

[10]  U. Yucetas,et al.  Is cystoscopy follow-up protocol safe for low-risk bladder cancer without muscle invasion? , 2019, Urology annals.

[11]  T. N. Harrison,et al.  The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer , 2019, Cancer Causes & Control.

[12]  Stef van Buuren,et al.  Flexible Imputation of Missing Data, Second Edition , 2018 .

[13]  S. Nabavi,et al.  Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment , 2018, Critical reviews in food science and nutrition.

[14]  C. Boushey,et al.  Examining Plausibility of Self-Reported Energy Intake Data: Considerations for Method Selection , 2017, Front. Nutr..

[15]  R. Turesky,et al.  Biomonitoring Human Albumin Adducts: The Past, the Present, and the Future , 2016, Chemical research in toxicology.

[16]  Li Tang,et al.  Cruciferous Vegetables, Isothiocyanates, and Prevention of Bladder Cancer , 2015, Current Pharmacology Reports.

[17]  Changhao Sun,et al.  Benefits and Risks of the Hormetic Effects of Dietary Isothiocyanates on Cancer Prevention , 2014, PloS one.

[18]  Kyungwon Oh,et al.  Dietary assessment methods in epidemiologic studies , 2014, Epidemiology and health.

[19]  C. Ambrosone,et al.  Total isothiocyanate yield from raw cruciferous vegetables commonly consumed in the United States. , 2013, Journal of functional foods.

[20]  Shivendra V. Singh,et al.  Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research. , 2012, Carcinogenesis.

[21]  Yuesheng Zhang.  The 1,2-Benzenedithiole-Based Cyclocondensation Assay: A Valuable Tool for the Measurement of Chemopreventive Isothiocyanates , 2012, Critical reviews in food science and nutrition.

[22]  T. D. de Reijke,et al.  Best practice in the treatment of nonmuscle invasive bladder cancer , 2012, Therapeutic advances in urology.

[23]  C. Pashos,et al.  The health economics of bladder cancer , 2012, PharmacoEconomics.

[24]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[25]  A. D. Di Pasqua,et al.  Proteins as binding targets of isothiocyanates in cancer prevention. , 2011, Carcinogenesis.

[26]  P. Vineis,et al.  Determination of new biomarkers to monitor the dietary consumption of isothiocyanates , 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[27]  K. Guru,et al.  Intake of Cruciferous Vegetables Modifies Bladder Cancer Survival , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[28]  Anoop Kumar,et al.  New biomarkers for monitoring the levels of isothiocyanates in humans. , 2010, Chemical research in toxicology.

[29]  Shang-Chiung Chen,et al.  Inhibition of bladder cancer development by allyl isothiocyanate. , 2010, Carcinogenesis.

[30]  E. Ho,et al.  Dietary agents as histone deacetylase inhibitors: sulforaphane and structurally related isothiocyanates. , 2008, Nutrition reviews.

[31]  K. Guru,et al.  Consumption of Raw Cruciferous Vegetables is Inversely Associated with Bladder Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[32]  Li Tang,et al.  Inhibition of urinary bladder carcinogenesis by broccoli sprouts. , 2007, Cancer research.

[33]  L. Tang,et al.  Discovery and development of sulforaphane as a cancer chemopreventive phytochemical , 2007, Acta Pharmacologica Sinica.

[34]  G. Kuttan,et al.  Immunomodulatory activity of Sulforaphane, a naturally occurring isothiocyanate from broccoli (Brassica oleracea). , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[35]  P. M. Reid,et al.  Cruciferous vegetable intake questionnaire improves cruciferous vegetable intake estimates. , 2007, Journal of the American Dietetic Association.

[36]  J. Stein,et al.  Superficial bladder cancer: part 1. Update on etiology, classification and natural history , 2006, Expert review of anticancer therapy.

[37]  Liguo Song,et al.  The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells , 2006, Anti-cancer drugs.

[38]  J Alfred Witjes,et al.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.

[39]  G. Kuttan,et al.  Augmentation of Natural Killer Cell and Antibody-Dependent Cellular Cytotoxicity in BALB/c Mice by Sulforaphane, a Naturally Occurring Isothiocyanate from Broccoli through Enhanced Production of Cytokines IL-2 and IFN-γ , 2006, Immunopharmacology and immunotoxicology.

[40]  Li Tang,et al.  Mitochondria are the primary target in isothiocyanate-induced apoptosis in human bladder cancer cells , 2005, Molecular Cancer Therapeutics.

[41]  Ronald B. Moore,et al.  A novel intravesical therapy for superficial bladder cancer in an orthotopic model: oncolytic reovirus therapy. , 2004, The Journal of urology.

[42]  Li Tang,et al.  Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. , 2004, The Journal of nutrition.

[43]  L. Tang,et al.  Selected isothiocyanates rapidly induce growth inhibition of cancer cells. , 2003, Molecular cancer therapeutics.

[44]  I. Tannock,et al.  The role of systemic chemotherapy in the management of muscle-invasive bladder cancer. , 2002, The Lancet. Oncology.

[45]  T. Shapiro,et al.  Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[46]  L. Kiemeney,et al.  Epidemiology of Bladder Cancer , 1999, European Urology.

[47]  P. Talalay,et al.  Quantitative determination of isothiocyanates, dithiocarbamates, carbon disulfide, and related thiocarbonyl compounds by cyclocondensation with 1,2-benzenedithiol. , 1996, Analytical biochemistry.

[48]  S. Jacobs,et al.  Late invasive recurrence despite long-term surveillance for superficial bladder cancer. , 1993, The Journal of urology.

[49]  David A. Schoenfeld,et al.  Partial residuals for the proportional hazards regression model , 1982 .